Cargando…
Galectin-3 Interacts with Vascular Cell Adhesion Molecule-1 to Increase Cardiovascular Mortality in Hemodialysis Patients
Background: Interactions and joint effects of galectin-3 and vascular cell adhesion molecule 1 (VCAM-1) on risks of all-cause and cardiovascular (CV) mortality remain unclear in patients with maintenance hemodialysis (MHD). Methods: Unadjusted and adjusted hazard ratios (aHRs) of mortality risks wer...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213523/ https://www.ncbi.nlm.nih.gov/pubmed/30249969 http://dx.doi.org/10.3390/jcm7100300 |
_version_ | 1783367792071802880 |
---|---|
author | Ko, Wen-Chin Choy, Cheuk-Sing Lin, Wei-Ning Chang, Shu-Wei Liou, Jian-Chiun Tung, Tao-Hsin Hsieh, Chih-Yu Chang, Jia-Feng |
author_facet | Ko, Wen-Chin Choy, Cheuk-Sing Lin, Wei-Ning Chang, Shu-Wei Liou, Jian-Chiun Tung, Tao-Hsin Hsieh, Chih-Yu Chang, Jia-Feng |
author_sort | Ko, Wen-Chin |
collection | PubMed |
description | Background: Interactions and joint effects of galectin-3 and vascular cell adhesion molecule 1 (VCAM-1) on risks of all-cause and cardiovascular (CV) mortality remain unclear in patients with maintenance hemodialysis (MHD). Methods: Unadjusted and adjusted hazard ratios (aHRs) of mortality risks were analyzed between higher and lower concentration groups of serum galectin-3 and VCAM-1. The modification effect between serum galectin-3 and VCAM-1 on mortality risk was investigated using an interaction product term. Results: During follow-up, galectin-3 and VCAM-1 were associated with incremental risks of all-cause mortality (aHR: 1.038 (95% confidence interval (CI): 1.001–1.077) and 1.002 (95% CI: 1.001–1.003), respectively). Nonetheless, VCAM-1 but not galectin-3 predicted CV mortality (aHR: 1.043 (95% CI: 0.993–1.096) and 1.002 (95% CI: 1.001–1.003), respectively). In the interaction analysis, patients with combined higher galectin-3 (>29.5 ng/mL) and VCAM-1 (>1546.9 ng/mL) were at the greatest risk of all-cause and CV mortality (aHR: 4.6 (95% CI: 1.6–13.4), and 4.2 (95% CI: 1.3–14.4), respectively). The interactions between galectin-3 and VCAM-1 with respect to all-cause and CV mortality were statistically significant (p < 0.01 and < 0.05, respectively). Conclusion: Galectin-3 and VCAM-1 could serve as a promising dual biomarker for prognostic assessment, considering their joint effects on pathogenesis of leukocyte trafficking and atherothrombosis. |
format | Online Article Text |
id | pubmed-6213523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62135232018-11-02 Galectin-3 Interacts with Vascular Cell Adhesion Molecule-1 to Increase Cardiovascular Mortality in Hemodialysis Patients Ko, Wen-Chin Choy, Cheuk-Sing Lin, Wei-Ning Chang, Shu-Wei Liou, Jian-Chiun Tung, Tao-Hsin Hsieh, Chih-Yu Chang, Jia-Feng J Clin Med Article Background: Interactions and joint effects of galectin-3 and vascular cell adhesion molecule 1 (VCAM-1) on risks of all-cause and cardiovascular (CV) mortality remain unclear in patients with maintenance hemodialysis (MHD). Methods: Unadjusted and adjusted hazard ratios (aHRs) of mortality risks were analyzed between higher and lower concentration groups of serum galectin-3 and VCAM-1. The modification effect between serum galectin-3 and VCAM-1 on mortality risk was investigated using an interaction product term. Results: During follow-up, galectin-3 and VCAM-1 were associated with incremental risks of all-cause mortality (aHR: 1.038 (95% confidence interval (CI): 1.001–1.077) and 1.002 (95% CI: 1.001–1.003), respectively). Nonetheless, VCAM-1 but not galectin-3 predicted CV mortality (aHR: 1.043 (95% CI: 0.993–1.096) and 1.002 (95% CI: 1.001–1.003), respectively). In the interaction analysis, patients with combined higher galectin-3 (>29.5 ng/mL) and VCAM-1 (>1546.9 ng/mL) were at the greatest risk of all-cause and CV mortality (aHR: 4.6 (95% CI: 1.6–13.4), and 4.2 (95% CI: 1.3–14.4), respectively). The interactions between galectin-3 and VCAM-1 with respect to all-cause and CV mortality were statistically significant (p < 0.01 and < 0.05, respectively). Conclusion: Galectin-3 and VCAM-1 could serve as a promising dual biomarker for prognostic assessment, considering their joint effects on pathogenesis of leukocyte trafficking and atherothrombosis. MDPI 2018-09-24 /pmc/articles/PMC6213523/ /pubmed/30249969 http://dx.doi.org/10.3390/jcm7100300 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ko, Wen-Chin Choy, Cheuk-Sing Lin, Wei-Ning Chang, Shu-Wei Liou, Jian-Chiun Tung, Tao-Hsin Hsieh, Chih-Yu Chang, Jia-Feng Galectin-3 Interacts with Vascular Cell Adhesion Molecule-1 to Increase Cardiovascular Mortality in Hemodialysis Patients |
title | Galectin-3 Interacts with Vascular Cell Adhesion Molecule-1 to Increase Cardiovascular Mortality in Hemodialysis Patients |
title_full | Galectin-3 Interacts with Vascular Cell Adhesion Molecule-1 to Increase Cardiovascular Mortality in Hemodialysis Patients |
title_fullStr | Galectin-3 Interacts with Vascular Cell Adhesion Molecule-1 to Increase Cardiovascular Mortality in Hemodialysis Patients |
title_full_unstemmed | Galectin-3 Interacts with Vascular Cell Adhesion Molecule-1 to Increase Cardiovascular Mortality in Hemodialysis Patients |
title_short | Galectin-3 Interacts with Vascular Cell Adhesion Molecule-1 to Increase Cardiovascular Mortality in Hemodialysis Patients |
title_sort | galectin-3 interacts with vascular cell adhesion molecule-1 to increase cardiovascular mortality in hemodialysis patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213523/ https://www.ncbi.nlm.nih.gov/pubmed/30249969 http://dx.doi.org/10.3390/jcm7100300 |
work_keys_str_mv | AT kowenchin galectin3interactswithvascularcelladhesionmolecule1toincreasecardiovascularmortalityinhemodialysispatients AT choycheuksing galectin3interactswithvascularcelladhesionmolecule1toincreasecardiovascularmortalityinhemodialysispatients AT linweining galectin3interactswithvascularcelladhesionmolecule1toincreasecardiovascularmortalityinhemodialysispatients AT changshuwei galectin3interactswithvascularcelladhesionmolecule1toincreasecardiovascularmortalityinhemodialysispatients AT lioujianchiun galectin3interactswithvascularcelladhesionmolecule1toincreasecardiovascularmortalityinhemodialysispatients AT tungtaohsin galectin3interactswithvascularcelladhesionmolecule1toincreasecardiovascularmortalityinhemodialysispatients AT hsiehchihyu galectin3interactswithvascularcelladhesionmolecule1toincreasecardiovascularmortalityinhemodialysispatients AT changjiafeng galectin3interactswithvascularcelladhesionmolecule1toincreasecardiovascularmortalityinhemodialysispatients |